Back to News
Market Impact: 0.3
Elucid Announces FDA Clearance of FFR-IQ™ and Commercial Availability of the Most Accurate¹ FFR-CT Software
Source: Business Wire
Healthcare & BiotechTechnology & InnovationRegulation & LegislationProduct Launches
Elucid received FDA 510(k) clearance for FFR-IQ, software that noninvasively estimates fractional flow reserve from coronary CT angiography. The clearance is a positive regulatory milestone; the article provides no financial or market-reaction figures.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.40
More News
- Meta put out an ambitious roadmap to Muse monetization after strong quarter and guide
- New Mexico took on Meta alone and won a $25 billion judgment over Facebook’s privacy violations
- Meta ordered to pay $25 billion in case related to Cambridge Analytica scandal
- Judge orders Meta to pay $25bn in fines for Facebook privacy violations
- Critical web security flaws spark global alarm as Google, OpenAI and Amazon respond
- Futures orbit around SpaceX as Tesla merger talk cheers investors